000 01506nam a2200409 i 4500
001 ocn961911482
003 OCoLC
005 20170826160830.0
006 m o d f
007 cr mn|||||||||
008 161102s1996 dcua ob f000 0 eng c
040 _aGPO
_beng
_erda
_epn
_cGPO
_dGPO
042 _apcc
043 _an-us---
074 _a0445-B-07 (online)
086 0 _aHE 1.75:OEI-03-94-00390
088 _aOEI-03-94-00390
099 _aHE 1.75:OEI-03-94-00390
110 1 _aUnited States.
_bDepartment of Health and Human Services.
_bOffice of Inspector General,
_eauthor.
245 1 0 _aMedicare payments for nebulizer drugs.
246 1 _iTitle from OIG web site:
_aPayments for prescription drugs used with nebulizers
264 1 _a[Washington, D.C.] :
_bDepartment of Health and Human Services, Office of Inspector General,
_c1996.
300 _a1 online resource ([27] pages) :
_billustrations
337 _2rdamedia
338 _2rdacarrier
588 _aDescription based on online resource; title from PDF title page (HHS, viewed Nov. 1, 2016).
500 _a"February 1996."
500 _a"OEI-03-94-00390."
500 _aCRDP Project record.
650 0 _aMedicare.
650 0 _aInhalers
_zUnited States
_xCosts.
650 0 _aDrug delivery devices
_zUnited States
_xFinance.
650 0 _aRespiratory therapy
_zUnited States
_xFinance.
856 4 0 _uhttp://purl.fdlp.gov/GPO/gpo69649
949 _aBEV
_bFed Docs
942 _c3
999 _c265425
_d265425